Circulation Research, Vol 68, 1742-1750, Copyright © 1991 by American Heart Association
ARTICLES |
WA Ng, IL Grupp, A Subramaniam and J Robbins
Division of Pediatric Cardiology, University of Cincinnati College of Medicine, OH 45267-0575.
The vertebrate heart contains two myosin heavy chain isoforms, alpha and beta, which are differentially expressed. To establish a murine model for gene-targeting experiments, we defined the precise temporal expression of the myosin isoforms during cardiogenesis and obtained quantitative measurements of cardiac performance. The relative levels of the alpha- and beta-cardiac transcripts were determined by isolating the RNA from the hearts of CD-1 mice during development and hybridizing the preparations to probes that detect specifically the alpha- or beta- cardiac myosin heavy chain mRNAs. The data indicate that, although both isoforms are present from the onset of cardiogenesis, the beta-isoform predominates during embryogenesis and fetal development. This relation is reversed after the first day of life with a significant drop in the absolute transcript levels during the switch; and alpha/beta ratio of 16:1 is maintained in the neonate, and the relatively high levels of the alpha-transcript remain throughout the adult stages. To be able to make functional comparisons between normal and transgenic mice, we obtained indexes of myocardial function in isolated retrogradely perfused and in work-performing heart preparations in normal and hypodynamic mouse hearts. We found that the physiology of the mouse heart is similar to the rat heart in that we observed a positive staircase in the force-frequency relation of the mouse Langendorff preparation. We also saw contractile responses of more than twice control induced by paired stimulation and persistent postextrasystolic potentiation. As is the case for the rat, in the work-performing mouse heart, afterload (Starling resistance, pressure) changes produced a steeper Starling function curve than did changes in preload (volume, venous return).
This article has been cited by other articles:
![]() |
N. Liu, S. Bezprozvannaya, A. H. Williams, X. Qi, J. A. Richardson, R. Bassel-Duby, and E. N. Olson microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart Genes & Dev., December 1, 2008; 22(23): 3242 - 3254. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tikellis, M. C. Thomas, B. E. Harcourt, M. T. Coughlan, J. Pete, K. Bialkowski, A. Tan, A. Bierhaus, M. E. Cooper, and J. M. Forbes Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E323 - E330. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wen, J. R. Pinto, A. V. Gomes, Y. Xu, Y. Wang, Y. Wang, J. D. Potter, and W. G. L. Kerrick Functional Consequences of the Human Cardiac Troponin I Hypertrophic Cardiomyopathy Mutation R145G in Transgenic Mice J. Biol. Chem., July 18, 2008; 283(29): 20484 - 20494. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Funakoshi, T. O. Chan, J. C. Good, J. R. Libonati, J. Piuhola, X. Chen, S. M. MacDonnell, L. L. Lee, D. E. Herrmann, J. Zhang, et al. Regulated Overexpression of the A1-Adenosine Receptor in Mice Results in Adverse but Reversible Changes in Cardiac Morphology and Function Circulation, November 21, 2006; 114(21): 2240 - 2250. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Grier, S. Xiong, A. C. Elizondo-Fraire, J. M. Parant, and G. Lozano Tissue-Specific Differences of p53 Inhibition by Mdm2 and Mdm4 Mol. Cell. Biol., January 1, 2006; 26(1): 192 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kido, L. Du, C. C. Sullivan, X. Li, R. Deutsch, S. W. Jamieson, and P. A. Thistlethwaite Hypoxia-Inducible Factor 1-Alpha Reduces Infarction and Attenuates Progression of Cardiac Dysfunction After Myocardial Infarction in the Mouse J. Am. Coll. Cardiol., December 6, 2005; 46(11): 2116 - 2124. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Kruger, S Zittrich, C Redwood, N Blaudeck, J James, J Robbins, G Pfitzer, and R Stehle Effects of the mutation R145G in human cardiac troponin I on the kinetics of the contraction-relaxation cycle in isolated cardiac myofibrils J. Physiol., April 15, 2005; 564(2): 347 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Golomb, X. Ma, S. S. Jana, Y. A. Preston, S. Kawamoto, N. G. Shoham, E. Goldin, M. A. Conti, J. R. Sellers, and R. S. Adelstein Identification and Characterization of Nonmuscle Myosin II-C, a New Member of the Myosin II Family J. Biol. Chem., January 23, 2004; 279(4): 2800 - 2808. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zahabi, S. Picard, N. Fortin, T. L. Reudelhuber, and C. F. Deschepper Expression of Constitutively Active Guanylate Cyclase in Cardiomyocytes Inhibits the Hypertrophic Effects of Isoproterenol and Aortic Constriction on Mouse Hearts J. Biol. Chem., November 28, 2003; 278(48): 47694 - 47699. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ponten, X. Li, P. Thoren, K. Aase, T. Sjoblom, A. Ostman, and U. Eriksson Transgenic Overexpression of Platelet-Derived Growth Factor-C in the Mouse Heart Induces Cardiac Fibrosis, Hypertrophy, and Dilated Cardiomyopathy Am. J. Pathol., August 1, 2003; 163(2): 673 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Schubert, X. Y. Yang, T. T.C. Yang, S. M. Factor, M. P. Lisanti, J. D. Molkentin, M. Rincon, and C.-W. Chow Requirement of transcription factor NFAT in developing atrial myocardium J. Cell Biol., June 9, 2003; 161(5): 861 - 874. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Siedner, M. Kruger, M. Schroeter, D. Metzler, W. Roell, B. K Fleischmann, J. Hescheler, G. Pfitzer, and R. Stehle Developmental changes in contractility and sarcomeric proteins from the early embryonic to the adult stage in the mouse heart J. Physiol., April 15, 2003; 548(2): 493 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sanbe, J. Gulick, M. C. Hanks, Q. Liang, H. Osinska, and J. Robbins Reengineering Inducible Cardiac-Specific Transgenesis With an Attenuated Myosin Heavy Chain Promoter Circ. Res., April 4, 2003; 92(6): 609 - 616. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Guo, K. Nakamura, J. Lynch, M. Opas, E. N. Olson, L. B. Agellon, and M. Michalak Cardiac-specific Expression of Calcineurin Reverses Embryonic Lethality in Calreticulin-deficient Mouse J. Biol. Chem., December 20, 2002; 277(52): 50776 - 50779. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Kirchhefer, H. A. Baba, Y. M. Kobayashi, L. R. Jones, W. Schmitz, and J. Neumann Altered function in atrium of transgenic mice overexpressing triadin 1 Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1334 - H1343. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shioi, J. R. McMullen, P. M. Kang, P. S. Douglas, T. Obata, T. F. Franke, L. C. Cantley, and S. Izumo Akt/Protein Kinase B Promotes Organ Growth in Transgenic Mice Mol. Cell. Biol., April 15, 2002; 22(8): 2799 - 2809. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Nerbonne, C. G. Nichols, T. L. Schwarz, and D. Escande Genetic Manipulation of Cardiac K+ Channel Function in Mice: What Have We Learned, and Where Do We Go From Here? Circ. Res., November 23, 2001; 89(11): 944 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Li, W. Guo, H. Xu, R. Hood, A. T. Benedict, and J. M. Nerbonne Functional expression of a GFP-tagged Kv1.5 alpha -subunit in mouse ventricle Am J Physiol Heart Circ Physiol, November 1, 2001; 281(5): H1955 - H1967. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zou, Y. Hiroi, H. Uozumi, E. Takimoto, H. Toko, W. Zhu, S. Kudoh, M. Mizukami, M. Shimoyama, F. Shibasaki, et al. Calcineurin Plays a Critical Role in the Development of Pressure Overload-Induced Cardiac Hypertrophy Circulation, July 3, 2001; 104(1): 97 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Demolombe, G. Lande, F. Charpentier, M. A van Roon, M. J.B van den Hoff, G. Toumaniantz, I. Baro, G. Guihard, N. Le Berre, A. Corbier, et al. Transgenic mice overexpressing human KvLQT1 dominant-negative isoform Part I: Phenotypic characterisation Cardiovasc Res, May 1, 2001; 50(2): 314 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Sheikh, D. P. Sontag, R. R. Fandrich, E. Kardami, and P. A. Cattini Overexpression of FGF-2 increases cardiac myocyte viability after injury in isolated mouse hearts Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1039 - H1050. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kishimoto, K. Rossi, and D. L. Garbers A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy PNAS, February 8, 2001; (2001) 51625598. [Abstract] [Full Text] |
||||
![]() |
K. Freeman, C. Colon-Rivera, M. C. Olsson, R. L. Moore, H. D. Weinberger, I. L. Grupp, K. L. Vikstrom, G. Iaccarino, W. J. Koch, and L. A. Leinwand Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H151 - H159. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Valencik and J. A. McDonald Cardiac expression of a gain-of-function {alpha}5-integrin results in perinatal lethality Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H361 - H367. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bou-Abboud, H. Li, and J. M Nerbonne Molecular diversity of the repolarizing voltage-gated K+ currents in mouse atrial cells J. Physiol., December 1, 2000; 529(2): 345 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Lemler, R. D. Bies, M. G. Frid, A. Sastravaha, L. S. Zisman, T. Bohlmeyer, A. M. Gerdes, J. T. Reeves, and K. R. Stenmark Myocyte cytoskeletal disorganization and right heart failure in hypoxia-induced neonatal pulmonary hypertension Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1365 - H1376. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Frey, W. M. Franz, K. Gloeckner, M. Degenhardt, M. Muller, O. Muller, H. Merz, and H. A. Katus Transgenic rat hearts expressing a human cardiac troponin T deletion reveal diastolic dysfunction and ventricular arrhythmias Cardiovasc Res, August 1, 2000; 47(2): 254 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Bartfay and E. Bartfay Iron-Overload Cardiomyopathy: Evidence for a Free Radical- Mediated Mechanism of Injury and Dysfunction in a Murine Model Biol Res Nurs, July 1, 2000; 2(1): 49 - 59. [Abstract] [PDF] |
||||
![]() |
J. C. Tardiff, T. E. Hewett, S. M. Factor, K. L. Vikstrom, J. Robbins, and L. A. Leinwand Expression of the beta (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects Am J Physiol Heart Circ Physiol, February 1, 2000; 278(2): H412 - H419. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Croissant, S. Carpenter, and D. Bader Identification and Genomic Cloning of CMHC1. A UNIQUE MYOSIN HEAVY CHAIN EXPRESSED EXCLUSIVELY IN THE DEVELOPING CHICKEN HEART J. Biol. Chem., January 21, 2000; 275(3): 1944 - 1951. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xu, D. M. Barry, H. Li, S. Brunet, W. Guo, and J. M. Nerbonne Attenuation of the Slow Component of Delayed Rectification, Action Potential Prolongation, and Triggered Activity in Mice Expressing a Dominant-Negative Kv2 {alpha} Subunit Circ. Res., October 1, 1999; 85(7): 623 - 633. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Bartfay, F. Dawood, W. H. Wen, D. C. Lehotay, D. Hou, E. Bartfay, X. Luo, P. H. Backx, and P. P. Liu Cardiac function and cytotoxic aldehyde production in a murine model of chronic iron-overload Cardiovasc Res, September 1, 1999; 43(4): 892 - 900. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xu, H. Li, and J. M Nerbonne Elimination of the transient outward current and action potential prolongation in mouse atrial myocytes expressing a dominant negative Kv4 {alpha} subunit J. Physiol., August 15, 1999; 519(1): 11 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Bluhm, M. Meyer, M.R. Sayen, E. A. Swanson, and W. H. Dillmann Overexpression of sarcoplasmic reticulum Ca2+-ATPase improves cardiac contractile function in hypothyroid mice Cardiovasc Res, August 1, 1999; 43(2): 382 - 388. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xu, W. Guo, and J. M. Nerbonne Four Kinetically Distinct Depolarization-activated K+ Currents in Adult Mouse Ventricular Myocytes J. Gen. Physiol., May 1, 1999; 113(5): 661 - 678. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Sugden Signaling in Myocardial Hypertrophy : Life After Calcineurin? Circ. Res., April 2, 1999; 84(6): 633 - 646. [Full Text] [PDF] |
||||
![]() |
D. M. Barry, H. Xu, R. B. Schuessler, and J. M. Nerbonne Functional Knockout of the Transient Outward Current, Long-QT Syndrome, and Cardiac Remodeling in Mice Expressing a Dominant-Negative Kv4 {alpha} Subunit Circ. Res., September 7, 1998; 83(5): 560 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. James and J. Robbins Molecular remodeling of cardiac contractile function Am J Physiol Heart Circ Physiol, November 1, 1997; 273(5): H2105 - H2118. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hein, M. E. Stevens, G. S. Barsh, R. E. Pratt, B. K. Kobilka, and V. J. Dzau Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block PNAS, June 10, 1997; 94(12): 6391 - 6396. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gulick, T. E. Hewett, R. Klevitsky, S. H. Buck, R. L. Moss, and J. Robbins Transgenic Remodeling of the Regulatory Myosin Light Chains in the Mammalian Heart Circ. Res., May 19, 1997; 80(5): 655 - 664. [Abstract] [Full Text] |
||||
![]() |
G. Chu, W. Luo, J. P. Slack, C. Tilgmann, W. E. Sweet, M. Spindler, K. W. Saupe, G. P. Boivin, C. S. Moravec, M. A. Matlib, et al. Compensatory Mechanisms Associated With the Hyperdynamic Function of Phospholamban-Deficient Mouse Hearts Circ. Res., December 1, 1996; 79(6): 1064 - 1076. [Abstract] [Full Text] |
||||
![]() |
Z. Yu, C. S. Redfern, and G. I. Fishman Conditional Transgene Expression in the Heart Circ. Res., October 1, 1996; 79(4): 691 - 697. [Abstract] [Full Text] |
||||
![]() |
W. Luo, B. M. Wolska, I. L. Grupp, J. M. Harrer, K. Haghighi, D. G. Ferguson, J. P. Slack, G. Grupp, T. Doetschman, R. J. Solaro, et al. Phospholamban Gene Dosage Effects in the Mammalian Heart Circ. Res., May 1, 1996; 78(5): 839 - 847. [Abstract] [Full Text] |
||||
![]() |
J. Palermo, J. Gulick, M. Colbert, J. Fewell, and J. Robbins Transgenic Remodeling of the Contractile Apparatus in the Mammalian Heart Circ. Res., March 1, 1996; 78(3): 504 - 509. [Abstract] [Full Text] |
||||
![]() |
B. D. Hoit, S. F. Khoury, E. G. Kranias, N. Ball, and R. A. Walsh In Vivo Echocardiographic Detection of Enhanced Left Ventricular Function in Gene-Targeted Mice With Phospholamban Deficiency Circ. Res., September 1, 1995; 77(3): 632 - 637. [Abstract] [Full Text] |
||||
![]() |
R.ée Ventura-Clapier, A. V. Kuznetsov, A. d'Albis, J. van Deursen, Bé Wieringa, and V. I. Veksler Muscle Creatine Kinase-deficient Mice J. Biol. Chem., August 25, 1995; 270(34): 19914 - 19920. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Uozumi, Y. Hiroi, Y. Zou, E. Takimoto, H. Toko, P. Niu, M. Shimoyama, Y. Yazaki, R. Nagai, and I. Komuro gp130 Plays a Critical Role in Pressure Overload-induced Cardiac Hypertrophy J. Biol. Chem., June 15, 2001; 276(25): 23115 - 23119. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kishimoto, K. Rossi, and D. L. Garbers A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy PNAS, February 27, 2001; 98(5): 2703 - 2706. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1991 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |